Evaluation of reward processes in an animal model of depression

被引:106
作者
Slattery, David A.
Markou, Athina
Cryan, John F. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Dept Pharmacol & Therapeut, Cork, Ireland
[2] Novartis Pharma AG, Novartis Pharma Inst BioMed Res, Neurosci Res, Basel, Switzerland
[3] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA
关键词
animal model; reward; depression; antidepressant;
D O I
10.1007/s00213-006-0630-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale Anhedonia is a core symptom of major depression. Deficits in reward function, which underlie anhedonia, can be readily assessed in animals. Therefore, anhedonia may serve as an endophenotype for understanding the neural circuitry and molecular pathways underlying depression. Objective Surprisingly, there is scant knowledge regarding alterations in brain reward function after olfactory bulbectomy (OB), an animal model which results in a behavioural syndrome responsive to chronic antidepressant treatment. Therefore, the present studies aimed to assess reward function after bulbectomy. Materials and methods The present study utilized sucrose preference, cocaine-induced hyperlocomotion and intra-cranial self-stimulation (ICSS) responding to examine reward processes in the OB model. Results Bulbectomized animals showed a marked preference (> 90%) for 0.8% sucrose solution compared with water; similar to the preference exhibited by sham controls. Importantly, there were pronounced deficits in brain reward function, as assessed using ICSS, which lasted 8 days before returning to baseline levels. Furthermore, bulbectomized animals were hyper-responsive to the locomotor stimulating properties of an acute and a repeated cocaine regimen. However, no difference in ICSS facilitation was observed in response to an acute cocaine injection. Conclusions Taken together, these results suggest that bulbectomized rats display alterations in brain reward function, but these changes are not long-lasting and thus, not amenable to investigating the effects of pharmacological interventions. However, given that OB animals are hypersensitive to drugs of abuse, bulbectomy may be an appropriate inducing factor for the development of animal models of co-morbid depression and drug dependence.
引用
收藏
页码:555 / 568
页数:14
相关论文
共 63 条
[1]  
Arango V, 2002, PROG BRAIN RES, V136, P443
[2]   Psychostimulant withdrawal as an inducing condition in animal models of depression [J].
Barr, AM ;
Markou, A .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (4-5) :675-706
[3]   Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice [J].
Brunner, D ;
Hen, R .
NEUROBIOLOGY OF SUICIDE: FROM THE BENCH TO THE CLINIC, 1997, 836 :81-105
[4]   Olfactory bulbectomy disrupts the expression of cocaine-induced conditioned place preference [J].
Calcagnetti, DJ ;
Quatrella, LA ;
Schechter, MD .
PHYSIOLOGY & BEHAVIOR, 1996, 59 (4-5) :597-604
[5]   Locomotor sensitization to cocaine in rats with olfactory bulbectomy [J].
Chambers, RA ;
Sheehan, T ;
Taylor, JR .
SYNAPSE, 2004, 52 (03) :167-175
[6]   Olfactory bulbectomy provokes a suppression of interleukin-1β and tumour necrosis factor-α production in response to an in vivo challenge with lipopolysaccharide:: Effect of chronic desipramine treatment [J].
Connor, TJ ;
Harkin, A ;
Kelly, JP ;
Leonard, BE .
NEUROIMMUNOMODULATION, 2000, 7 (01) :27-35
[7]   Role of IL-1 in poststroke depressive-like behavior in mice [J].
Craft, Tara K. S. ;
DeVries, A. Courtney .
BIOLOGICAL PSYCHIATRY, 2006, 60 (08) :812-818
[8]   The ascent of mouse: Advances in modelling human depression and anxiety [J].
Cryan, JF ;
Holmes, A .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (09) :775-790
[9]   Assessing antidepressant activity in rodents: recent developments and future needs [J].
Cryan, JF ;
Markou, A ;
Lucki, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) :238-245
[10]   Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents [J].
Cryan, JF ;
Hoyer, D ;
Markou, A .
BIOLOGICAL PSYCHIATRY, 2003, 54 (01) :49-58